The FDA has broadened its warning regarding a Salmonella Typhimurium and Newport outbreak associated with moringa leaf powder supplements, with 119 confirmed instances now reported across 36 states in the U.S. as of the June 12, 2026 update. This strain is resistant to medication, complicating treatment compared to standard Salmonella infections. Several supplement brands have been pulled from shelves, and the FDA is advising consumers to cease the use of all moringa supplements immediately. The outbreak traces back to moringa leaf powder products available at major retailers and online, with the FDA undertaking a comprehensive traceback to pinpoint all impacted lot numbers.
